Nonetheless, our results completes the previous observation that esophageal cancers expressing the P-type ATPase ATP7B, a platinum exporter, are more resistant to cisplatin than ATP7B-negative tumors (Higashimoto et al., 2003; Burger et al., 2011). This evidence concerns the gene ATP7B and esophageal cancer.